Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ali Niak
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0000-0003-3404-3212
Observed ORCID:
0000-0003-3404-3212
OpenAlex ID:
A5004956121
Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients
2024
·
Steven T. Bird
, Elizabeth R. Smith
, et al.
·
JAMA
·
100
PDF
Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration
2022
·
Daniel Woronow
, Christine Chamberlain
, et al.
·
JAMA Internal Medicine
·
38
Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database
2017
·
Sarah Kang
, Ali Niak
, et al.
·
Contraception
·
37
The Effect of Denosumab on Risk for Emergently Treated Hypocalcemia by Stage of Chronic Kidney Disease: A Target Trial Emulation
2024
·
Steven T. Bird
, Kate Gelperin
, et al.
·
Annals of Internal Medicine
·
26
Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System
2015
·
S. Christopher Jones
, Debra L. Ryan
, et al.
·
Diabetes Spectrum
·
19
Show more works
View as search
Works count:
5
Citation count:
220
H-index:
5
I10-index:
5
Year
Topic
Type